SCHEMBL31466752

SCHEMBL31466752

O=C(O)c1cccc2nc(O)ccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.52
NR4A2 P43354 1/20 0.52
NR4A3 Q92570 1/20 0.52
ALDH1A1 P00352 3/20 0.50
PTPN1 P18031 1/20 0.49
AKR1C3 P42330 1/20 0.46
AKR1C2 P52895 1/20 0.46
AKR1C1 Q04828 1/20 0.46
KDM4E B2RXH2 4/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 1/20 0.46
PDE10A Q9Y233 1/20 0.46
POLB P06746 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
DHODH Q02127 2/20 0.44
ALOX15 P16050 1/20 0.43
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
KDM4A O75164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17433761 1.00 NR4A1 (0.52) NR4A1NR4A2NR4A3ALDH1A1PTPN1
Naphthoic Acid SCHEMBL28057383 0.83 NR4A1 (0.66) NR4A1NR4A2NR4A3ALDH1A1PTPN1
SCHEMBL1133932 0.81 KDM4E (0.54) ALDH1A1KDM4ELMNAPOLBMEN1
SCHEMBL2806839 0.81 MGAM (0.58) NR4A1NR4A2NR4A3ALDH1A1PTPN1
SCHEMBL8421614 0.81 NPC1 (0.58) NR4A1NR4A2NR4A3ALDH1A1PTPN1
Potassium SCHEMBL8421620 0.81 NPC1 (0.58) NR4A1NR4A2NR4A3ALDH1A1PTPN1
SCHEMBL30048398 0.79 ALDH1A1 (0.51) NR4A1NR4A2NR4A3ALDH1A1PTPN1
SCHEMBL2289118 0.79 ALDH1A1 (0.51) NR4A1NR4A2NR4A3ALDH1A1PTPN1
SCHEMBL27562798 0.79 NR4A1 (0.50) NR4A1NR4A2NR4A3ALDH1A1PTPN1
SCHEMBL12701071 0.79 NR4A1 (0.50) NR4A1NR4A2NR4A3ALDH1A1PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250034128-A1 BCL-XL INHIBITORS BEIGENE, LTD. (KY) 2025-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250034128-A1 BCL-XL INHIBITORS BCL2, BCL2L1, BCL2L10 NR4A1 3630/4885NR4A2 2528/4885NR4A3 2659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.